ScholarIQanswers from OpenAlex & ORCID
Kirkwood F. Adams
ResearcherPublications, citations & collaboration network
Kirkwood F. Adams is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kirkwood F. Adams have?
ScholarIQindexed works
Kirkwood F. Adams has 336 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kirkwood F. Adams have?
ScholarIQcitation count
Kirkwood F. Adams has 28,216 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kirkwood F. Adams?
ScholarIQh-index
Kirkwood F. Adams has an h-index of 72 in OpenAlex.
What is the i10-index of Kirkwood F. Adams?
ScholarIQi10-index
Kirkwood F. Adams has an i10-index of 189 in OpenAlex.
What is the OpenAlex record for Kirkwood F. Adams?
ScholarIQopenalex
The OpenAlex for Kirkwood F. Adams is on the source record.
What are the most-cited papers on Kirkwood F. Adams?
ScholarIQmost cited works
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
Kirkwood F. Adams, Gregg C. Fonarow, Charles L. Emerman, Thierry H. LeJemtel, Maria Rosa Costanzo, William T. Abraham, Robert Berkowitz, Marie Galvao, Darlene P. Horton
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Anne L. Taylor, Susan Ziesche, Clyde W. Yancy, Peter E. Carson, Ralph B. D’Agostino, Keith C. Ferdinand, Malcolm P. Taylor, Kirkwood F. Adams, Michael L. Sabolinski, Manuel Worcel, Jay N. Cohn
Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure
Michael R. Bristow, Edward M. Gilbert, William T. Abraham, Kirkwood F. Adams, Michael B. Fowler, Ray E. Hershberger, Spencer H. Kubo, Kenneth A. Narahara, Henry Ingersoll, Steven K. Krueger, Sarah Young, Neil H. Shusterman
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
Cathal O’Connor, Randall C. Starling, Adrian F. Hernandez, Paul W. Armstrong, Kenneth Dickstein, Vic Hasselblad, Gretchen Heizer, Michel Komajda, Barry M. Massie, John J.V. McMurray, Markku S. Nieminen, Craig J. Reist, Jean L. Rouleau, Karl Swedberg, Kirkwood F. Adams, Stefan D. Anker, Dan Atar, A Battler, Rodrigo Botero, N. R. Bohidar, Javed Butler, Nadine Clausell, Ramón Corbalán, Maria Rosa Costanzo, Ulf Dahlström, Lawrence I. Deckelbaum, Rafael Díaz, Mark E. Dunlap, Justin A. Ezekowitz, DO Bruce Feldman, G. Michael Felker, Gregg C. Fonarow, Daniel Gennevois, Stephen S. Gottlieb, James A. Hill, Judd E. Hollander, Jonathan G. Howlett, Michael Hudson, Robb D. Kociol, Henry Krum, Aleksandras Laucevičius, Wayne C. Levy, Gustavo Méndez, Marco Metra, Sanjay Mittal, Byung‐Hee Oh, Naveen L. Pereira, Piotr Ponikowski, W.H. Wilson Tang, Supachai Tanomsup, John R. Teerlink, F. Triposkiadis, Richard W. Troughton, Adriaan A. Voors, David J. Whellan, Faı̈ez Zannad, Robert M. Califf
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
John R. Teerlink, Gad Cotter, Beth A. Davison, G. Michael Felker, Gerasimos Filippatos, Barry Greenberg, Piotr Ponikowski, Elaine Unemori, Adriaan A. Voors, Kirkwood F. Adams, Maria I. Dorobantu, Liliana Grinfeld, Guillaume Jondeau, Alon Marmor, Josep Masip, Peter S. Pang, Karl Werdan, Sam L. Teichman, Angelo J. Trapani, Christopher Bush, Rajnish Saini, Christoph Schumacher, Thomas M. Severin, Marco Metra